Plain-English translation of NCT07013201 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether , applied twice daily to the hands and feet, can reduce the pustules and symptoms of palmoplantar pustulosis (a rare skin condition causing painful blisters on palms and soles). Half of the participants will receive the active medication, and half will receive a plain cream with no medicine, so researchers can fairly compare how well the treatment works.
Current treatments for this condition, like topical steroids, don't work well for many patients or may not be safe for long-term use. This trial is exploring whether this new medication offers a better option.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic about 9 times over 18 weeks. You'll apply either the active cream or a plain cream to your hands and feet twice daily for 16 weeks. The research team will photograph your skin and assess how many pustules you have and how severe they look. You'll be asked to follow all the instructions carefully and report any side effects or concerns at your visits.
AI-generated summary from trial data · Sep 15, 2026 · Not medical advice
United States